Pregabalin Market by Application and Geography - Forecast and Analysis 2022-2026

Published: Sep 2022

Pages: 123

SKU: IRTNTR74278

Snapshot

The pregabalin market share is expected to increase by USD 153.03 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 3.74%.

This pregabalin market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers pregabalin market segmentations by application (neuropathic pain, epilepsy, anxiety disorders, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The pregabalin market report also offers information on several market vendors, including Biomax Biotechnics Pvt. Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Kumars Pharmaceuticals, Genesis Biotec Inc., H. L. Healthcare Pvt. Ltd., Lupin Ltd, Medley Pharmaceuticals Ltd., MK Medicine, MSN Laboratories, Neuracle Lifesciences Pvt. Ltd., Novartis AG, Pfizer Inc., Phoenix Biologicals Pvt. Ltd., Sun Pharmaceutical Industries Ltd, Swastik Life Sciences, Torrent Pharmaceuticals Ltd., and Vibcare Pharma Pvt. Ltd. among others.

What will the Pregabalin Market Size be During the Forecast Period?

Download Report Sample to Unlock the Pregabalin Market Size for the Forecast Period and Other Important Statistics

Pregabalin Market: Key Drivers, Trends, and Challenges

The presence of a large patient pool related to neuropathic pain is notably driving the pregabalin market growth, although factors such as growing preference for alternatives may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the pregabalin industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Pregabalin Market Driver

The presence of a large patient pool related to neuropathic pain is one of the key drivers supporting the pregabalin market growth. Neuropathic pain is associated with various disorders such as diabetic neuropathy, chemotherapy-induced pain, shingles, and herniated disk. There have been growing cases of these disorders, especially in the geriatric population. Meanwhile, the increasing number of individuals preferring chemotherapy for cancer treatment is fueling cases of chemotherapy-induced pain. Furthermore, according to the CDC, the incidence of shingles is approximately four per 1,000 US population annually. Overall, there are an estimated one million cases of herpes zoster in the US annually. Such a scenario will lead to an increase in the adoption of pregabalin, which, in turn, will drive the growth of the market during the forecast period.

Key Pregabalin Market Trend

Growing focus on emerging economies is one of the key pregabalin market trends contributing to the market growth. The increasing incidence of individuals with various diseases such as neuropathic pain, epilepsy, anxiety disorders, and fibromyalgia has fueled the demand for pregabalin in regions such as China, India, and Brazil. In addition, the research institutes have issued guidelines to address the unmet needs in the treatment of such incidences. Moreover, vendors are also looking to tap the potential in emerging economies. For instance, Pfizer, Cipla, and Lupin are some of the companies that are increasingly conducting R&D activities to develop effective treatments in APAC. Such initiatives are expected to positively impact the growth of the global pregabalin market during the forecast period.

Key Pregabalin Market Challenge

Growing preference for alternatives is one of the key factors hindering the pregabalin market growth. As the current treatments are associated with many unmet needs, end-users are looking to shift to alternative therapies. For instance, diabetic neuropathic pain can be reduced by supplementing essential acids, alpha-lipoic acid, gamma-linolenic acid, and omega-3 fatty acids. Similarly, acupuncture can be an effective way to manage peripheral neuropathy. Acupuncture uses pressure points across the body to realign the body's energy. Thus, the use of these alternative therapies may hinder growth prospects in the forecast period.

This pregabalin market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global pregabalin market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the pregabalin market during the forecast period.

Who are the Major Pregabalin Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

This statistical study of the pregabalin market encompasses successful business strategies deployed by the key vendors. The pregabalin market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

pfizer.com - Under the unified segment, the company is engaged in the discovery, development, manufacturing, marketing, sales, and distribution of biopharmaceutical products worldwide.
pfizer.com - The company offers pregabalin such as Lyrica and Lyrica CR.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The pregabalin market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the leading companies' production, sustainability, and prospects.

Pregabalin Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the pregabalin market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Pregabalin Market?

For more insights on the market share of various regions Request PDF Sample now!

36% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the pregabalin market in North America. Market growth in this region will be faster than the growth of the market in Europe.

The increase in the older population, coupled with the established adoption of LYRICA and Cymbalta in new indications and the introduction of new drugs for the treatment of neuropathic pain, will facilitate the pregabalin market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 negatively impacted the regional market. However, the initiation of large-scale COVID-19 vaccination drives by the government in Q4 2020 led to a decrease in the number of COVID-19 cases in the region. This has resulted in the resumption of operations in healthcare facilities, which has increased the manufacturing of pregabalin in North America.

What are the Revenue-generating Application Segments in the Pregabalin Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The pregabalin market share growth in the neuropathic pain segment will be significant during the forecast period. Neuropathic pain affects 20% to 30% of diabetic neuropathy patients. Thus, the demand for pregabalin is rising due to more occurrences of diabetic neuropathy, which is boosting the growth of the market. Pregabalin is an alternative treatment for people with neuropathic pain that has not responded to other drugs. It effectively reduces the symptoms of numerous neuropathic pain conditions and positions itself as a first-line therapy option with exceptional safety and efficacy. These factors will drive segment growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the pregabalin market size and actionable market insights on the post-COVID-19 impact on each segment.

Pregabalin Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 3.74%
Market growth 2022-2026	$153.03 million
Market structure	Fragmented
YoY growth (%)	3.27
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 36%
Key consumer countries	US, Canada, Germany, China, Japan, and Republic of Korea
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Biomax Biotechnics Pvt. Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Kumars Pharmaceuticals, Genesis Biotec Inc., H. L. Healthcare Pvt. Ltd., Lupin Ltd, Medley Pharmaceuticals Ltd., MK Medicine, MSN Laboratories, Neuracle Lifesciences Pvt. Ltd., Novartis AG, Pfizer Inc., Phoenix Biologicals Pvt. Ltd., Sun Pharmaceutical Industries Ltd, Swastik Life Sciences, Torrent Pharmaceuticals Ltd., and Vibcare Pharma Pvt. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Pregabalin Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive pregabalin market growth during the next five years
Precise estimation of the pregabalin market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the pregabalin industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of pregabalin market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

5.1 Market segments
- Exhibit 24: Chart on Application - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

5.2 Comparison by Application
- Exhibit 26: Chart on Comparison by Application
- Exhibit 27: Data Table on Comparison by Application

5.3 Neuropathic pain - Market size and forecast 2021-2026
- Exhibit 28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)

5.4 Epilepsy - Market size and forecast 2021-2026
- Exhibit 32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)

5.5 Anxiety disorders - Market size and forecast 2021-2026
- Exhibit 36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)

5.6 Others - Market size and forecast 2021-2026
- Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)

5.7 Market opportunity by Application
- Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.10 China - Market size and forecast 2021-2026
- Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

7.11 Japan - Market size and forecast 2021-2026
- Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)

7.12 Republic of Korea - Market size and forecast 2021-2026
- Exhibit 86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
- Exhibit 87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
- Exhibit 88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
- Exhibit 89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)

7.13 Market opportunity by geography
- Exhibit 90: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 91: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 92: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 93: Overview on factors of disruption

9.4 Industry risks
- Exhibit 94: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 95: Vendors covered

10.2 Market positioning of vendors
- Exhibit 96: Matrix on vendor position and classification

10.3 Biomax Biotechnics Pvt. Ltd.
- Exhibit 97: Biomax Biotechnics Pvt. Ltd. - Overview
- Exhibit 98: Biomax Biotechnics Pvt. Ltd. - Product / Service
- Exhibit 99: Biomax Biotechnics Pvt. Ltd. - Key offerings

10.4 Camber Pharmaceuticals Inc.
- Exhibit 100: Camber Pharmaceuticals Inc. - Overview
- Exhibit 101: Camber Pharmaceuticals Inc. - Product / Service
- Exhibit 102: Camber Pharmaceuticals Inc. - Key offerings

10.5 Cipla Ltd.
- Exhibit 103: Cipla Ltd. - Overview
- Exhibit 104: Cipla Ltd. - Business segments
- Exhibit 105: Cipla Ltd. - Key news
- Exhibit 106: Cipla Ltd. - Key offerings
- Exhibit 107: Cipla Ltd. - Segment focus

10.6 Genesis Biotec Inc.
- Exhibit 108: Genesis Biotec Inc. - Overview
- Exhibit 109: Genesis Biotec Inc. - Product / Service
- Exhibit 110: Genesis Biotec Inc. - Key offerings

10.7 Lupin Ltd
- Exhibit 111: Lupin Ltd - Overview
- Exhibit 112: Lupin Ltd - Product / Service
- Exhibit 113: Lupin Ltd - Key news
- Exhibit 114: Lupin Ltd - Key offerings

10.8 Medley Pharmaceuticals Ltd.
- Exhibit 115: Medley Pharmaceuticals Ltd. - Overview
- Exhibit 116: Medley Pharmaceuticals Ltd. - Product / Service
- Exhibit 117: Medley Pharmaceuticals Ltd. - Key offerings

10.9 MK Medicine
- Exhibit 118: MK Medicine - Overview
- Exhibit 119: MK Medicine - Product / Service
- Exhibit 120: MK Medicine - Key offerings

10.10 Novartis AG
- Exhibit 121: Novartis AG - Overview
- Exhibit 122: Novartis AG - Business segments
- Exhibit 123: Novartis AG - Key offerings
- Exhibit 124: Novartis AG - Segment focus

10.11 Pfizer Inc.
- Exhibit 125: Pfizer Inc. - Overview
- Exhibit 126: Pfizer Inc. - Product / Service
- Exhibit 127: Pfizer Inc. - Key news
- Exhibit 128: Pfizer Inc. - Key offerings

10.12 Torrent Pharmaceuticals Ltd.
- Exhibit 129: Torrent Pharmaceuticals Ltd. - Overview
- Exhibit 130: Torrent Pharmaceuticals Ltd. - Business segments
- Exhibit 131: Torrent Pharmaceuticals Ltd. - Key offerings
- Exhibit 132: Torrent Pharmaceuticals Ltd. - Segment focus

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 133: Inclusions checklist
- Exhibit 134: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 135: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 136: Research methodology
- Exhibit 137: Validation techniques employed for market sizing
- Exhibit 138: Information sources

11.5 List of abbreviations
- Exhibit 139: List of abbreviations

Population

pressure

in incidence rate

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

pregabalin market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis